Marc E. Lippman
Impact in
- Oncology top 0.05%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer Risks and Factors
- Cancer Research top 0.05%
- Breast Cancer Treatment Studies
- Cancer, Hypoxia, and Metabolism
Papers in
- Genetics 162
- Estrogen and related hormone effects 139
- Co-authors
- Robert B. Dickson (65 shared papers)Karen Huff (27 shared papers)E. Brad Thompson (26 shared papers)Gail Bolan (8 shared papers)Diane Bronzert (22 shared papers)Joseph C. Allegra (17 shared papers)Cornelius Knabbe (12 shared papers)Attan Kasid (11 shared papers)
- Journals
- Breast Cancer Research and Treatment (51 papers)Journal of Biological Chemistry (17 papers)Journal of Clinical Oncology (16 papers)Endocrinology (15 papers)Cancer (10 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Marc E. Lippman
415 papers receiving 30.2k citations
Marc E. Lippman's Hit Papers
Peers
Comparison fields: 5 of 178
- Oncology 12.1k
- Cancer Research 6.6k
- Genetics 10.1k
- Endocrinology, Diabetes and Metabolism 4.0k
- Immunology and Allergy 1.1k
Countries citing papers authored by Marc E. Lippman
This map shows the geographic impact of Marc E. Lippman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc E. Lippman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc E. Lippman more than expected).
Fields of papers citing papers by Marc E. Lippman
This network shows the impact of papers produced by Marc E. Lippman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc E. Lippman. The network helps show where Marc E. Lippman may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc E. Lippman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 424 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women Hit paper breakdown → | 1999 | 1528 |
| 2 | Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells Hit paper breakdown → | 1987 | 883 |
| 3 | The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture. Hit paper breakdown → | 1976 | 744 |
| 4 | Breast Cancer Hit paper breakdown → | 1992 | 616 |
| 5 | Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study Hit paper breakdown → | 2017 | 597 |
| 6 | Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial Hit paper breakdown → | 2001 | 550 |
| 7 | erbB-2 and Response to Doxorubicin in Patients With Axillary Lymph Node-Positive, Hormone Receptor- Negative Breast Cancer Hit paper breakdown → | 1998 | 536 |
| 8 | Estrogenic Regulation of Growth and Polypeptide Growth Factor Secretion in Human Breast Carcinoma Hit paper breakdown → | 1987 | 532 |
| 9 | Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. Hit paper breakdown → | 1990 | 522 |
| 10 | 2003 | 462 | |
| 11 | 1992 | 456 | |
| 12 | Targeting RAGE Signaling in Inflammatory Disease Hit paper breakdown → | 2017 | 410 |
| 13 | 1989 | 372 | |
| 14 | 1974 | 353 | |
| 15 | Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. | 1978 | 348 |
| 16 | 1995 | 340 | |
| 17 | 1975 | 303 | |
| 18 | 2004 | 298 | |
| 19 | Characterization of estrogen responsive transforming activity in human breast cancer cell lines. | 1986 | 296 |
| 20 | Insulin-like growth factor receptor expression and function in human breast cancer. | 1990 | 294 |
About Marc E. Lippman
Marc E. Lippman is a scholar working on Molecular Biology, Genetics, Oncology, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 424 papers that have together received 32.3k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (139 papers), HER2/EGFR in Cancer Research (49 papers), Breast Cancer Treatment Studies (48 papers), Cancer Cells and Metastasis (41 papers), Growth Hormone and Insulin-like Growth Factors (35 papers), Cancer, Hypoxia, and Metabolism (23 papers), Cancer Treatment and Pharmacology (22 papers) and Monoclonal and Polyclonal Antibodies Research (21 papers). The work is most often cited by research in Oncology (12.1k citations), Cancer Research (6.6k citations), Genetics (10.1k citations), Endocrinology, Diabetes and Metabolism (4.0k citations) and Immunology and Allergy (1.1k citations). Marc E. Lippman has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Robert B. Dickson, Karen Huff, E. Brad Thompson, Gail Bolan, Diane Bronzert, Joseph C. Allegra, Cornelius Knabbe, Attan Kasid, Robert Clarke and David N. Danforth. Their work appears in journals such as Breast Cancer Research and Treatment, Journal of Biological Chemistry, Journal of Clinical Oncology, Endocrinology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.